@FiercePharma: Bioprinting winning converts in Singapore. FiercePharmaAsia item | Follow @FiercePharma
@EricPFierce: ICYMI: Roche whacking 1,200 jobs, closing plants in US, Ireland, Italy and Spain, but building one in Switzerland. Story | Follow @EricPFierce
@CarlyHFierce: Boehringer ups the ante in IPF drug race with awareness funding. More from FiercePharmaMarketing | Follow @CarlyHFierce
> Baxalta ($BXLT) won FDA approval for its long-acting hemophilia A drug Adynovate, which the company hopes will help boost sales despite increasing competition in the field. Report | More
> Novo Nordisk ($NVO) "has never been in a better position," despite rivals' warnings about insulin sales slumps, CEO Lars Rebien Sørensen said in an interview. Report
> Sweden's Meda, whose dermatology drug Elidel is licensed in the U.S. to Valeant Pharmaceuticals ($VRX), could see sales disruptions from its partner's specialty pharmacy woes. Report
Medical Device News
@FierceMedDev: ICYMI: Crime syndicates are hacking devices to steal private medical information for profit. Article | Follow @FierceMedDev
@VarunSaxena2: @HillaryClinton says Medicare should negotiate for lower drug prices. @BernieSanders rips Big Pharma, too. Uh oh! | Follow @VarunSaxena2
@EmilyWFierce: Gilead scores additional indications for Harvoni in hep C, HIV patients. FiercePharma story | Follow @EmilyWFierce
> J&J to launch suite of orthopedics 'solutions' for outpatient joint replacement. Report
> SurgiQuest snapped up for $265M ahead of proposed IPO, rounding out Conmed surgical offerings. Article
> Omada Health trumpets promising results from study of digital health program in Medicare patients. More
Biotech News
@FierceBiotech: RIP: Failure-prone KaloBios pulls the plug, calls in the liquidators. More | Follow @FierceBiotech
@JohnCFierce: Did Sanofi ($SNY) drag its feet on Lemtrada to save on the CVR? (Or is it just a lousy drug?). More from the NYT | Follow @JohnCFierce
@DamianFierce: Bloomberg's use of up-style headlines has resulted in a piece of art. Item | Follow @DamianFierce
> Moving on from Novartis, Array inks a $455M oncology deal with Pierre Fabre. Report
> Baxalta wins FDA OK for a long-acting Advate, padding its hemophilia biz. News
> Clovis craters after lung cancer drug hits FDA road block, data deteriorate. Article
Animal Health News
> Heska beats the Street on revenue and earnings in Q3. More
> Aratana unveils branding and partnering plans at investor day. Report
> Merck reiterates dedication to animal health with Harrisvaccines acquisition. Article
> Phibro seeks growth in aquaculture as Q1 sales growth slows. Story
> ImmuCell soars on Q3 sales growth. Item
Biotech IT News
> Datatrak accused of 'shameless and amateurish scare tactics' as proxy fight turns nasty. Report
> What represents success to 23andMe's Wojcicki? Developing a cure for a major disease. More
> WuXi NextCODE lands starring role in 100,000 Genomes Project. Story
> FDA starts beta testing 'the most advanced bioinformatics platform in the world.' More
> Data-gathering implantable chips to be tested in schizophrenia trial. Article
Pharma Marketing News
> Depomed's staffed-up Nucynta salesforce starts bringing home the bacon. Report
> Merck to forge ahead with CETP-inhibiting cholesterol med. Item
> *NSYNC's Joey Fatone lends pearly whites to Colgate diabetes campaign. Story
> Snafus waiting to happen? Pharma's digital silos stymie end-to-end promo management. More
> Boehringer ups the ante in IPF drug race with awareness funding. Article
And Finally... GlaxoSmithKline ($GSK) is readying new regulatory submissions for its injectable form of the lupus drug Benlysta. Report